1. Home
  2. MSLE vs QTRX Comparison

MSLE vs QTRX Comparison

Compare MSLE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$6.78

Market Cap

144.6M

Sector

N/A

ML Signal

N/A

Logo Quanterix Corporation

QTRX

Quanterix Corporation

N/A

Current Price

$2.85

Market Cap

135.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MSLE
QTRX
Founded
2018
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
144.6M
135.3M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
MSLE
QTRX
Price
$6.78
$2.85
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
★ $24.17
$3.17
AVG Volume (30 Days)
45.1K
★ 459.6K
Earning Date
11-15-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $37,632,000.00
Revenue This Year
N/A
$3.21
Revenue Next Year
N/A
$9.96
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 64.52
52 Week Low
$5.44
$2.15
52 Week High
$13.39
$8.77

Technical Indicators

Market Signals
Indicator
MSLE
QTRX
Relative Strength Index (RSI) 38.43 44.09
Support Level $5.52 $2.84
Resistance Level $10.58 $3.99
Average True Range (ATR) 0.54 0.18
MACD 0.06 -0.00
Stochastic Oscillator 22.18 28.03

Price Performance

Historical Comparison
MSLE
QTRX

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: